BIG PHARMA PROFITEERING

Pfizer, Moderna raise vaccine prices in EU

Vaccines from both drugmakers have been approved in the EU for children from 12 to 17 years of age.



The EU expects to receive more than a billion doses from four drugmakers by the end of September

Pfizer and Moderna have increased the prices of their vaccines in their latest European Union supply contracts, the Financial Times newspaper reported.

The new price for BioNTech-Pfizer's shot is €19.50 ($23.15), compared with €15.50 ($18.40) previously. The price of the Moderna shot is now €21.50, an increase of €2.50.

The European Medicines Agency (EMA), the EU's medicines watchdog, said last Friday that the bloc was likely to get 40 million more Moderna vaccine doses by October.

The European Commission said last week that the EU was on course to fully vaccinate at least 70% of its adult population by the end of the summer.

Overall, 57% of people over 18 are now fully vaccinated across 27 nations, Commission Chief Ursula von der Leyen said in a statement. She warned that people could not let their guard down since the "very dangerous" delta variant was still a threat.